Operating Expenses - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Operating Expenses Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Operating Expenses
-ÂŁ15.3B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
A
AstraZeneca PLC
NASDAQ:AZN
Operating Expenses
-$30.1B
CAGR 3-Years
-18%
CAGR 5-Years
-16%
CAGR 10-Years
-5%
Indivior PLC
LSE:INDV
Operating Expenses
-$688m
CAGR 3-Years
-20%
CAGR 5-Years
-8%
CAGR 10-Years
-5%
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Expenses
-$813m
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-7%
Allergy Therapeutics PLC
LSE:AGY
Operating Expenses
-ÂŁ66.8m
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
-9%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Expenses
-ÂŁ404.7m
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
-17%

See Also

What is GlaxoSmithKline PLC's Operating Expenses?
Operating Expenses
-15.3B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Operating Expenses amounts to -15.3B GBP.

What is GlaxoSmithKline PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-3%

Over the last year, the Operating Expenses growth was -16%. The average annual Operating Expenses growth rates for GlaxoSmithKline PLC have been -4% over the past three years , -2% over the past five years , and -3% over the past ten years .

Back to Top